December 11-13, 2024 | Edinburgh, Scotland
Proveris Laboratories are exhibition sponsors, and poster presenters at the Drug Delivery to the Lungs (DDL) conference which will be held December 11-13.
The scientific poster collaboration with H&T Presspart on ‘A Tale of 3 Propellants: Understanding the In Vitro Characteristics of a Solution pMDI’ highlights the necessity of actuator geometry optimization and the adoption of new plume characterisation methodologies to achieve in vitro equivalence in the development of low GWP pMDIs.
Representatives from Proveris will be available for private meetings throughout the conference. To find out more, or to arrange a meeting, please email contactus@proveris.com.
Drug Delivery to the Lungs Conference (DDL) is in its 35th year and attracts more than 1000 attendees worldwide, including scientists, academics, clinicians, regulators and industry experts. The conference includes a large industry exhibition, supported by over 100 international companies, a scientific poster hall, expert lectures and excellent networking opportunities over the 3-day event.
Learn more and register here: DDL – Annual forum for developing medicines for inhalation (ddl-conference.com)